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liver tissues, adipose tissue and is then also affects the 
function of β cells of the pancreas which secretes the 
insulin.3 diabetes is the most common endocrine disor-
der and by the year of 2025, it is estimated that around 
300 million people will suffer from this disease.4-6 The 
cause of diabetes can be a genetic or due to the vari-
ous inappropriate life factors such as cigarette smok-
ing, physical inactivity, sedentary lifestyle and regular 
alcohol consumption. Among the two types of diabetes 
mellitus; type ii occurs especially due to the genetic, 
behavioral risk factors combined with environmental 
factors.7, 8 GLP-1 agonist and DPP-IV are the two thera-
peutic approaches of diabetes mellitus resulting into the 
balancing of blood sugar level in fasting as well as in 
diabetes mellitus is a heterogeneous metabolic dis-order in which the β cells of pancreas dysfunctions 
resulting into the improper secretion of insulin which 
ultimately leads to the irregular blood sugar level along 
with the disturbance in the carbohydrate, fat, and pro-
tein metabolism.1, 2 Based on the etiology and clinical 
presentation, diabetes is common of four major types 
which are type I diabetes, type II diabetes, gestational 
and other specific diabetes. Among the several types of 
diabetes; type ii diabetes mellitus has higher dominance 
in the developing countries which leads to the distur-
bance of insulin level affecting the concentration of the 
blood glucose level. Type ii diabetes mellitus is fol-
lowed by the resistance of insulin of muscular tissues, 
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Diabetes mellitus is becoming the critical problem among the entire world and it is difficult to understand the molecular mechanism represent-
ing the concept of diabetic pathology. Recently the knowledge of the involvement of genetics in type 2 diabetes mellitus (T2DM) susceptibility 
has sketched a great concentration towards the transcriptional activity of β cells within the pancreas. This disease becomes the leading cause of 
death, so it is necessary to study the molecular pathogenesis, phenotypes, and characteristics to design the therapeutic parameters. Here in this 
review role of miRNA is being illustrated as it plays a crucial role in the pathogenesis, progression, and fate of beta cells of pancreas regulating 
the insulin secretion. Here in this review, we try to include the effects and pathophysiology of various miRNA in diabetes mellitus and on the 
various sites of the human body.
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thology and physiology of various disease like cardio-
vascular disease, cancer, diabetes by interfering in the 
development and function of β cells thus misbalancing 
the concentration of insulin and various other diseases. 
it is found that mirNa functions by rNa silencing and 
regulating post transcriptionally which represents the 
changes in the mi rNa processing and stability to the 
gene expression by binding to the specific sites in the 3′ 
untranslated region of their target mirNas.15-17
miRNA shows participation in the β cell biology, in-
sulin resistance, type i and type ii diabetes mellitus and 
its various complication in whole anatomy and physiol-
ogy of the human being. alteration in the mirNa may 
postprandial condition and shows the therapeutic effect 
on the proper functioning of β cells of pancreas.9-11
microrNa is the family of small endogenous non-
coding single stranded rNa molecule in eukaryotes 
having 17-25 nucleotides which were first described in 
nematode Caenorhabditis elegans in 1993. microrNas 
are important regulatory molecules in many biological 
processes.12-14 miRNA plays a significant role in the 
regulatory mechanisms operating in various organisms 
including the developmental timing and host pathogen 
interaction, and it also has a major role in cell differ-
entiation, tumorigenesis, apoptosis and proliferation 
which ultimately results in the modulation of the pa-
Table I.—Role of various miRNA in the pathophysiology of diabetes mellitus.22-46
Name Target sites expression Pathophysiology role in diabetes Species
mir-15a 22, 23 Skeletal muscle Down involved in cell cycle regulation, 
regulates gene expression in 
metabolism
Promotes insulin biosynthesis by inhibiting 
endogenous UcP-2 (uncoupling protein-2) 
expression in mouse β cells
Human
mir-9 24-26 endothelial 
cells
Down Pancreatic islets differentiation and 
development
responsible for insulin secretion by encoding 
respective genes, Onecut 2; also inhibits the 
expression of granuphilin which is a negative 
regulator of insulin exocytosis
Human
mir-29a 27-29 White adipose 
tissue
Up Interaction with multiple 
transcription factors such as 
PPars and adipocyte enriched to 
regulate many aspects of lipid and 
glucose metabolism
increased expression of this mirNas could 
be involved in the initial cellular response of 
adipocytes to hyperglycemia
rat, human
mir-124a 30-33 Pancreas Down Vital for pancreatic β cell 
development modulates 
exocytosis system by directly 
targeting Foxa 2
Found in an increased amount in diabetic 
patient and directly target to GTPase rab 27a 
to negatively regulate insulin secretion
Human
mir-96 34 Serum Up Negatively associated with 
granuphilin but not interferes with 
Onecut2
Negatively regulates insulin exocytosis Human
mir-375 35-37 Serum Up β cell proliferation and is 
responsible for maintaining the 
normal pancreatic β cell mass
By targeting the number of growth inhibiting 
genes and is required for β cell proliferation 









mir-21 39, 40 Serum Up β cell differentiation β cell differentiation of pancreatic progenitor 
cells and may be involved in vascular 









Down β cell differentiation β cell differentiation of hPSCs differentiated 
IPCs also decreases fibronectin in diabetes in 
the retinas, kidneys, and hearts
Human
mir-222 27, 43 adipose tissue Up directly inhibits to P27KiP1 and 
P57KiP2
it mediates vascular damage in HG and 
advanced glycation end-product in diabetic 
mice
rats
mir-27a 44-46 adipose tissue Up Targets the epidermal growth factor 
in which promotes tumorigenesis 
in several breast cancers
Patients diagnosed with metabolic syndrome 
and T2dm have increased level of mir-27a
rat
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15a and mir-15b has been suggested by Joglekar et al. 
in 2007 (Figure 1).31
Some mirNa is found in human islets in large con-
centration like mir-375, mir-7-5p, mir-148a-3p, 
mir-26a-5p, and mir-127-3p.32-34 Pancreas agenesis 
occurs due to the total inactivation of mirNa matura-
tion which represents the necessity of miRNA for early 
phase development.34
Discussion
although a distinct number of articles or studies are 
available describing the effect of microrNa in diabetes 
mellitus; their up regulation, down regulation in various 
physiological parameters. In this review article, we try 
to provide a relation between the various miRNA and 
their role in diabetes. also, it expresses the biological 
function of microrNa and pathophysiology of mirNa 
in diabetes mellitus. mirNa involves in the cell differ-
entiation, cell proliferation, apoptosis and neuronal cell 
death which results in some diseased conditions includ-
ing diabetes, e.g. mir-375 involves in the cell prolifera-
tion. miR-15a interferes with the metabolism to regulate 
gene expression.35, 36 discussed regarding some mirNa 
machinery gene responsible for the formation of several 
mirNa affecting the glucose metabolism.37, 38 mir-222 
and miR-27a shows its effect on adipose tissue by up-
regulation in rat species.39-41 In this review, we accu-
mulate the different parameters related to the effect of 
mirNa on various tissues of distinct species like hu-
man and rats.
act as an early marker for the changes in the diabetes 
homeostasis and can be for the therapeutic targets of 
diabetes.18, 19 mirNa involved in the pathogenesis of 
diabetes mellitus by interfering in the β cell membrane 
electrical excitation (initiated by an increase in the ratio 
of ATP and ADP), insulin synthesis, the fate of β cell, 
pancreatic mass formation and exocytosis processes 
which include docking, fusion, and exocytosis of insu-
lin granules. disturbance in the regulation of mirNa is 
responsible for the impairment of the glucose metabo-
lism (Table i).20, 21
Human pancreatic cells and miRNA
A specific subset of miRNA plays a crucial role in 
the regulation and functioning of alpha and beta cells 
of pancreas among which β cells are responsible for the 
secretion of insulin managing the diabetic influences. 
For example, mir-24, mir-26, and mir-148 contribute 
to the characterization and management of pancreatic β 
cells.22 mirNas are involved in the development, apop-
tosis, cell proliferation and in the neuronal cell fate and 
is altered in several disorders like diabetes, autoimmune 
diseases, cardiovascular and exhibit diversity in the 
metabolic control for the proper functioning of different 
cells, tissues, organs of the human body. Some mirNa 
machinery genes such as such as drosha, DGCR8, Dic-
er1, XPO5, TRBP, and AGO2 are responsible for the 
formation of protein processing the various mirNas 
affecting to the physiology of several organs and their 
system.23, 24 Dicer is required for maintaining the adult 
pancreas and dysregulation of Dicer1 in β cells results 
into the impaired islets architecture, decreased insulin 
secretion, exhibit glucose tolerance, and development 
of diabetes.25, 26 miR-375 mediates the β-cells prolif-
eration which is observed in obesity and pregnancy as 
well this miR-375 also suggested as the keen player 
in the network on interacting with transcription factor 
that is responsible for the pancreatic development and 
maintenance of their β cells of islets of Langerhans.27, 28 
Tattikota et al. have recently illustrated that ago2 par-
ticipates in the insulin secretion and β cells compensa-
tory expansion and also found that its level is increased 
during insulin resistance which is necessary for β-cells 
compensatory expansion occurs during insulin resistant 
state.29, 30 Pancreatic regeneration possibly by targeting 
the Ngn3 by the influence of miR-195, miR-16, miR-
Figure 1.—Pathogenesis of mirNa in diabetes mellitus.
dysregulation of drosha/ablation of dicer-1
Blocked mirNa processing
mir-24, mir-26, mir-148, mir-182
Stimulates transcriptional repressors such as Bhlhe22 and SOX6
decreases insulin promoter activity and quantity of corresponding mrNa
defects in development of endocrine pancreatic lineages 
especially insulin producing β cells
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From this review, it can be concluding that miRNA 
exhibits the potential contribution in the pathogenesis 
and thus in the treatment of diabetes mellitus also. But 
there is a need to give keen concentration for the thera-
peutic parameters for the healthy survival of diabetic 
patients by minimizing their various side effects.
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